FDA NDC Directory · JSON-LD · Markdown

ELEVIDYS

NDC 60923-511 · HUMAN PRESCRIPTION DRUG · KIT

Generic namedelandistrogene moxeparvovec-rokl
Labeler / ManufacturerSarepta Therapeutics, Inc.
Marketing categoryBiologic License Application · App BLA125781
Dosage form / routeKIT · INTRAVENOUS
Active ingredients—
Marketing started20230622
Package count1

External sources

Source: openFDA. Public-domain (CC0).